Page 18 - Breakthrough Devices Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Investigators Report Positive Findings From Feasibility Study of CCM in Heart Failure With Preserved Ejection Fraction at the European Society of...

Late-breaking Results Show Efficacy for CCM in Patients With HFpEF Investigators Report Positive Findings From Feasibility Study of CCM in Heart Failure With Preserved Ejection Fraction at the European Society of Cardiology Heart Failure 2022 Congress GlobeNewswire May 23, 2022 MADRID and MARLTON, N.J., May 23, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics,...

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005313/en/ Exactech Announces FDA Breakthrough Device Designation for

Designation to promote more rapid Agency and market access for VenoStentHOUSTON, TX / ACCESSWIRE / May 17, 2022 / VenoStent, Inc., a clinical-stage tissue engineering company developing bioabsorbable perivascular